Skip to main content
. Author manuscript; available in PMC: 2022 May 1.
Published in final edited form as: J Pediatr. 2021 Jan 20;232:65–72.e7. doi: 10.1016/j.jpeds.2021.01.031

Table 6:

24-month follow-up availability by treatment arm

Placebo Epo
Number/ Total (%) Number/ Total (%) p-value
Died prior to 24-months 42/ 454 (9.3%) 49/ 469 (10.4%) 0.55
Alive at 24 months 412 / 454 (90.7%) 420 / 469 (89.6%)
 Alive at 24 months, no follow-up 13 / 412 (3.2%) 35 / 420 (8.3%) 0.01
 24 month follow-up conducted 397 / 412 (96.4%) 383 / 420 (91.2%)
  Blood and urine 140 / 397 (35.3%) 123 / 383 (32.1%) 0.1
  blood only 50 / 397 (12.6%) 47 / 383 (12.3%)
  urine only 78 / 397 (19.6%) 104 / 383 (27.2%)
  neither blood or urine 129 / 397 (32.5%) 109 / 383 (28.5%)
 Blood Pressure measured 258/394 (65.5%) 234/383 (61.1%) 0.24
 Weight kg, mean (sd) 11.5 (1.8) 11.2 (1.8) 0.48
 Height cm, mean (sd) 84.7 (4.7) 85.0 (4.2) 0.08